|
|
|
SENSEX
|
|
-52.63
|
-0.07%
|
73953.31
|
|
|
NIFTY
|
|
27.05
|
0.12%
|
22529.05
|
|
|
Nasdaq
|
|
108.90
|
0.65%
|
16794.87
|
|
|
Nikkei 225
|
|
282.30
|
0.73%
|
39069.68
|
|
|
FTSE 100
|
|
3.90
|
0.05%
|
8424.20
|
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
Caplin Point Laboratories Ltd.
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
BSE Code |
524742
|
ISIN Demat |
INE475E01026
|
Book Value (Rs) |
183.05
|
|
NSE Code |
CAPLIPOINT
|
Dividend Yield % |
0.19
|
Market Cap (Rs) |
98021.81
|
|
TTM PE(x) |
34.55
|
TTM EPS(Rs) |
37.36
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
Incorporation Year
|
1990
|
Registered Office
|
3rd Floor, “ Ashvich Towers”,No.3, Developed Plots Industrial Estate,Perungudi, Chennai, Tamil Nadu-600096 .
|
ISINNO
|
INE475E01026
|
Phone
|
044-24968000 / 8012772888 / 71148000
|
E-mail
|
info@caplinpoint.net |
URL
|
www.caplinpoint.net |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
C C Paarthipan
|
Managing Director
|
Sridhar Ganesan
|
Company Secretary
|
G Venkatram
|
Listing
|
BSE,NSE,Chennai
|
|
|
|
|
|
|
|
|
|
|
|